201 related articles for article (PubMed ID: 32495877)
1. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2.
Gao WY; Yang G; Wang J; He JM; Wang P
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
3. LINC00657 promotes malignant progression of oral squamous cell carcinoma via regulating microRNA-150.
Xu FY; Xu X; Hu XD
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2482-2490. PubMed ID: 32196599
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
Ye J; Jiao Y
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-378 promotes the malignant progression of oral squamous cell carcinoma by mediating FOXN3.
Ding N; Luo M; Liao XL; Bao QY; Li RY; Wu B
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6202-6210. PubMed ID: 31364120
[TBL] [Abstract][Full Text] [Related]
7. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
[TBL] [Abstract][Full Text] [Related]
8. PRKD3 promotes malignant progression of OSCC by downregulating KLF16 expression.
Chen Z; Huang Q; Xu W; Wang H; Yang J; Zhang LJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12709-12716. PubMed ID: 33378018
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LACAT1 promotes proliferation of oral squamous cell carcinoma cells by inhibiting microRNA-4301.
Wang J; Huo F; Wang XR; Xu YY
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2427-2435. PubMed ID: 30964168
[TBL] [Abstract][Full Text] [Related]
10. CSN6 promotes the cell migration of breast cancer cells by positively regulating Snail1 stability.
Mou J; Wei L; Liang J; Du W; Pei D
Int J Med Sci; 2020; 17(17):2809-2818. PubMed ID: 33162808
[No Abstract] [Full Text] [Related]
11. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
Wang X; Chen T
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA CASC2 alleviates the growth, migration and invasion of oral squamous cell carcinoma via downregulating CDK1.
Xing HB; Qiu HM; Li Y; Dong PF; Zhu XM
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4777-4783. PubMed ID: 31210307
[TBL] [Abstract][Full Text] [Related]
13. Circ-ABCB10 accelerates the malignant progression of oral squamous cell carcinoma by absorbing miRNA-145-5p.
Chen F; Li XH; Liu C; Zhang Y; Wang RJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):681-690. PubMed ID: 32016969
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
[TBL] [Abstract][Full Text] [Related]
15. CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis.
Shi J; Guan X; Zhan F; Liu C; Li Z; Yao Y; Wang B; Lou C; Zhang Y
Cancer Biol Ther; 2019; 20(9):1290-1299. PubMed ID: 31311398
[TBL] [Abstract][Full Text] [Related]
16. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).
Pramanik KK; Mishra R
Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997
[TBL] [Abstract][Full Text] [Related]
17. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2.
Tao D; Zhang Z; Liu X; Zhang Z; Fu Y; Zhang P; Yuan H; Liu L; Cheng J; Jiang H
Mol Carcinog; 2020 Apr; 59(4):353-364. PubMed ID: 31995261
[TBL] [Abstract][Full Text] [Related]
19. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
Zhang LL; Hu D; Zou LH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
